Rab5a‑mediated autophagy regulates the phenotype and behavior of vascular smooth muscle cells.
Rab5a, a key member of the Rab family of GTPases, was determined to be a regulator of vascular smooth muscle cell (VSMC) proliferation and migration. However, the exact regulatory mechanism remains unclear. As Rab5a has been shown to be associated with autophagy, which is essential for the conversion of VSMCs from a contractile to a synthetic phenotype in order to prevent cell death due to oxidative stress. The present study hypothesized that autophagy may be responsible for the proliferation and migration of VSMCs via the Rab5a protein. The aim of the present study was to evaluate the effect of Rab5a on autophagy in VSMCs. The human aorta vascular smooth muscle cell line, T/G HA‑VSMCs, was treated with small interfering (si)RNA against Rab5a and/or platelet‑derived growth factor (PDGF). Following treatment, the phenotype transition of the VSMCs was evaluated by detecting the mRNA and protien expression levels of VSMC molecular markers using reverse transcription‑quantitative polymerase chain reaction and western blotting, respectively. In addition, autophagy in VSMCs was evaluated by western blotting for autophagy‑associated proteins, flow cytometry of acidic vesicular organelles, punctate fluorescence of microtubule associated protein light chain 3 and transmission electron microscopy of typical scattered double‑membrane vacuolar structures. Additionally, the proliferation, migration, cell cycle and apoptotic response of VSMCs were detected by sulforhodamine B assay, transwell assay and flow cytometry, respectively. The results revealed that transfection with siRNA against Rab5a led to a significant decrease in Rab5a protein expression, while the reduced expression trend of Rab5a was rescued by intervention with PDGF. Furthermore, cells transfected with siRNA against Rab5a inhibited the autophagy of VSMCs. Downregulated Rab5a inhibited the phenotype transition of VSMCs. Additionally, downregulated Rab5a led to slowed cell growth, decreased numbers of migrated cells, decreased numbers of cells at the G0‑G1 phase and a higher apoptosis rate. However, PDGF significantly rescued these phenomena caused by siRNA against Rab5a. These results indicated that Rab5a‑mediated autophagy may regulate the phenotype transition and cell behavior of VSMCs through the activation of the extracellular‑regulated kinase 1/2 signaling pathway.
Department of Surgery, Huashan Hospital of Fudan University, Shanghai 200040, P.R. China.
Jin-Yun
JY
Tan
Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital of Fudan University, Shanghai 200011, P.R. China.
Luo-Qi
LQ
Jia
Department of Surgery, Huashan Hospital of Fudan University, Shanghai 200040, P.R. China.
Wei-Hao
WH
Shi
Department of Surgery, Huashan Hospital of Fudan University, Shanghai 200040, P.R. China.
Qing
Q
He
Department of Surgery, Huashan Hospital of Fudan University, Shanghai 200040, P.R. China.
Lei
L
Zhu
Department of Surgery, Pudong Hospital of Fudan University, Shanghai 201399, P.R. China.
Bo
B
Yu
D001011:Aorta / Q000166:cytology / Q000378:metabolism; D001343:Autophagy / Q000235:genetics*; D002460:Cell Line; D002465:Cell Movement / Q000235:genetics; D049109:Cell Proliferation / Q000235:genetics; D005786:Gene Expression Regulation / Q000187:drug effects; D006801:Humans; D009131:Muscle, Smooth, Vascular / Q000166:cytology* / Q000378:metabolism; D032389:Myocytes, Smooth Muscle / Q000166:cytology* / Q000378:metabolism; D018384:Oxidative Stress; D010982:Platelet-Derived Growth Factor / Q000235:genetics* / Q000378:metabolism; D034741:RNA, Small Interfering / Q000235:genetics; D020696:rab5 GTP-Binding Proteins / Q000037:antagonists & inhibitors / Q000096:biosynthesis* / Q000235:genetics
D010982:Platelet-Derived Growth Factor; D034741:RNA, Small Interfering; C427755:RAB5C protein, human; D020696:rab5 GTP-Binding Proteins
Circ Res. 1997 Oct;81(4):600-10
9314842
J Biol Chem. 2000 Jul 21;275(29):22537-43
10807920
J Biomed Sci. 2011 Aug 17;18:58
21849022
Biochem J. 2013 May 1;451(3):375-88
23421427
FEBS J. 2010 Jan;277(1):2-21
19843174
Biochim Biophys Acta. 2007 Aug;1773(8):1213-26
17112607
Oncogene. 2011 Nov 10;30(45):4544-56
21577201
FASEB J. 1997 Nov;11(13):1119-26
9367346
Arterioscler Thromb Vasc Biol. 2011 Jul;31(7):1495-505
21677292
Methods. 2001 Dec;25(4):402-8
11846609
Curr Pharm Des. 2010 Jan;16(1):101-13
20214621
Nature. 2012 Feb 22;485(7396):55-61
22367541
Traffic. 2005 Dec;6(12 ):1070-7
16262719
Am J Pathol. 2010 Jul;177(1):4-9
20558573
J Cell Sci. 2008 May 15;121(Pt 10):1649-60
18430781
J Clin Invest. 2008 Dec;118(12):3837-40
19033653
Am J Physiol Cell Physiol. 2012 Jan 15;302(2):C383-91
22031599
Crit Rev Eukaryot Gene Expr. 2014;24(4):341-55
25403963
Proc Natl Acad Sci U S A. 2006 Aug 8;103(32):11821-7
16882731
Cancer Sci. 2010 Jun;101(6):1454-62
20412119
BMC Genomics. 2009 Mar 17;10 :113
19292924
Physiol Rev. 2011 Jan;91(1):119-49
21248164
Circ Res. 2010 Feb 19;106(3):514-25
20019333
Autophagy. 2014 Feb;10(2):257-68
24321786
Cancer Sci. 2011 Dec;102(12):2172-8
21895870
Autophagy. 2011 Feb;7(2):176-87
21081844
J Virol. 2011 Oct;85(20):10561-71
21835792
J Pharmacol Exp Ther. 2001 Sep;298(3):1172-8
11504817
Science. 2012 Nov 16;338(6109):956-9
23112296
Physiol Rev. 2004 Jul;84(3):767-801
15269336
Nat Rev Mol Cell Biol. 2005 Jun;6(6):439-48
15928708
Acta Med Indones. 2007 Apr-Jun;39(2):86-93
17933075
Hepatol Res. 2007 Nov;37(11):957-65
17581187
Acta Cardiol. 2010 Oct;65(5):507-14
21125971
Dev Cell. 2004 Apr;6(4):463-77
15068787
J Biol Chem. 2009 Aug 7;284(32):21412-24
19520853